• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate

  2026-07-14

  This study presents a robust method for synthesizing deuterium-labeled degarelix acetate, a third-generation GnRH receptor antagonist integral to prostate cancer research. The approach enables the production of stable isotope-labeled internal standards, advancing clinical pharmacokinetic and hormone regulation studies.

• 7-Ethyl-10-hydroxycamptothecin: Dual Mechanisms in Colon Can

  2026-07-13

  7-Ethyl-10-hydroxycamptothecin, also known as SN-38, is a potent DNA topoisomerase I inhibitor and apoptosis inducer in colon cancer cells. It demonstrates cell cycle arrest in S and G2 phases and uniquely disrupts FUBP1–DNA binding, expanding its utility in advanced colon cancer research.

• Danazol in Endocrine Models: Protocols, Use-Cases & Troubles

  2026-07-13

  Danazol (Danocrine) is indispensable for modeling steroidogenesis inhibition and HPG axis modulation, enabling robust studies of precocious puberty and prostate cancer. This guide delivers stepwise workflows, actionable troubleshooting, and a synthesis of the latest reference advances for reproducible, high-impact research.

• Modified Degarelix Analogs: Stereochemistry and GnRH Antagon

  2026-07-12

  This study explores the effects of stereospecific modification at position 3 of Degarelix, a potent GnRH receptor antagonist, using 3-(2-methoxy-5-pyridyl)-alanine. The research reveals key structure-activity relationships that inform future design of peptide-based antagonists for hormone-dependent cancer therapy.

• Alda 1: ALDH2 Activator for Cardiac Ischemia Research Workfl

  2026-07-10

  Alda 1 uniquely empowers advanced cardiac ischemia and dermatitis models by robustly activating both wild-type and ALDH2*2 enzyme variants. This guide translates cutting-edge ALDH2 activation research into actionable protocols and troubleshooting strategies for high-impact experimental outcomes.

• iPSC-Based Drug Testing Platforms for Cystic Fibrosis Resear

  2026-07-09

  This study introduces a multimodal platform using induced pluripotent stem cell (iPSC)-derived airway epithelial cells to assess cystic fibrosis (CF) drug responses. The approach enables genotype-specific functional assays, supporting preclinical evaluation of therapies for both common and rare CFTR variants.

• Amikacin Disulfate: Mechanistic Insights for Translational R

  2026-07-09

  Explore the transformative role of Amikacin disulfate, a semisynthetic aminoglycoside antibiotic, in unraveling protein synthesis suppression and antibiotic resistance mechanisms. This article connects advanced mechanistic findings—highlighting lysozyme–drug interactions—to practical guidance for translational researchers, setting a new standard for scientific rigor and strategic experimental design.

• Exercise-Induced Muscle EVs Enhance Amyloid Clearance in AD

  2026-07-08

  This study demonstrates that swimming exercise increases skeletal muscle-derived extracellular vesicle (SKM-EV) secretion, which is taken up by microglia in Alzheimer’s disease (AD) mouse models to enhance amyloid-beta plaque clearance. The findings reveal a novel muscle-brain signaling pathway, mediated by miR-378a-3p, that offers new mechanistic insight and translational potential for AD intervention strategies.

• Applied Workflows with Ertapenem Sodium Salt in Resistance R

  2026-07-08

  Ertapenem sodium salt empowers researchers to dissect multidrug resistance mechanisms in Gram-positive and Gram-negative bacteria with high precision. This article details optimized experimental workflows, troubleshooting tactics, and practical protocol parameters, drawing on recent epidemiological breakthroughs to guide advanced antibiotic resistance assays.

• VE-821 ATR Kinase Inhibitor: Precision Epigenetics in DDR As

  2026-07-07

  Explore how VE-821, a leading ATR kinase inhibitor, is redefining DNA repair pathway and radiosensitization studies through a new lens—precision epigenetic modulation. This article offers a deep scientific analysis linking DDR inhibition with practical assay design, leveraging the latest insights for advanced research.

• Cabozantinib (XL184) in RCC: Protocols, Adaptation, and Opti

  2026-07-07

  Unlock advanced renal cell carcinoma (RCC) research with Cabozantinib (XL184) by leveraging timescale-dependent signaling insights and robust antiangiogenic workflows. This guide translates phosphoproteomic discoveries into actionable protocols, troubleshooting strategies, and next-generation assay enhancements for scientists seeking reproducible, mechanism-driven results.

• 2'3'-cGAMP (sodium salt): Benchmarking STING Pathway Activat

  2026-07-06

  2'3'-cGAMP (sodium salt) is a potent endogenous STING agonist and key tool for dissecting the cGAS-STING signaling pathway. Its high binding affinity and robust type I interferon induction establish it as a gold-standard reagent for immunology and translational research.

• Atorvastatin in HMG-CoA Reductase Inhibitor Research: Advanc

  2026-07-06

  Atorvastatin is redefining experimental strategies in both cholesterol metabolism and ferroptosis-driven cancer research. This article provides actionable protocols, troubleshooting guidance, and a translation of the latest reference findings for scientists using APExBIO's Atorvastatin in vascular and oncology models.

• CHIR-99021 (CT99021): Elevating Stem Cell Differentiation Pr

  2026-07-05

  CHIR-99021 (CT99021) unlocks reproducible control over pluripotency and lineage commitment in stem cell workflows through precise, selective GSK-3 inhibition. Its robust performance in Wnt/β-catenin signaling modulation positions it as a gold-standard reagent for advanced differentiation, from cardiomyocytes to neurons.

• nor-Binaltorphimine Dihydrochloride in κ-Opioid Antagonist A

  2026-07-04

  nor-Binaltorphimine dihydrochloride delivers unmatched selectivity for κ-opioid receptor antagonist assays, enabling researchers to dissect pain circuits and opioid signaling with precision. Recent circuit-level discoveries inform optimized workflows, troubleshooting, and protocol enhancements for advanced pain modulation research.

16746 records 1/1117 page Next 12345 下5页 Last page